Literature DB >> 28396226

Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites.

Masaya Koshizaka1, Renato D Lopes2, L Kristin Newby2, Robert M Clare2, Phillip J Schulte2, Pierluigi Tricoci2, Kenneth W Mahaffey3, Hisao Ogawa4, David J Moliterno5, Robert P Giugliano6, Kurt Huber7, Stefan James8, Robert A Harrington3, John H Alexander2.   

Abstract

BACKGROUND: Most diabetes and cardiovascular studies have been conducted in white patients, with data being extrapolated to other population groups.
METHODS: For this analysis, patient-level data were extracted from 5 randomized clinical trials in patients with acute coronary syndrome; we compared obesity levels between Asian and white populations, stratified by diabetes status. By using an adjusted Cox proportional hazards model, hazard ratios (HRs) for cardiovascular outcomes after an acute coronary syndrome were determined.
RESULTS: We identified 49,224 patient records from the 5 trials, with 3176 Asians and 46,048 whites. Whites with diabetes had higher body mass index values than those without diabetes (median 29.3 vs 27.2 kg/m2; P < .0001), whereas Asians with diabetes and without diabetes had similar body mass index (24.7 vs 24.2 kg/m2). Asians with diabetes (HR, 1.63; 95% confidence interval [CI], 1.32-2.02), whites with diabetes (HR, 1.15; 95% CI, 1.06-1.25), and Asians without diabetes (HR, 1.36; 95% CI, 1.14-1.64) had higher rates of the composite of death, myocardial infarction, or stroke at 30 days than whites without diabetes. Asians with diabetes (HR, 1.84; 95% CI, 1.47-2.31), whites with diabetes (HR, 1.47; 95% CI, 1.33-1.62), and Asians without diabetes (HR, 1.38; 95% CI, 1.11-1.73) had higher rates of death at 1 year compared with whites without diabetes. There were no significant interactions between race and diabetes for ischemic outcomes.
CONCLUSIONS: Although Asians with diabetes and acute coronary syndrome are less likely to be obese than their white counterparts, their risk for death or recurrent ischemic events was not lower.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Diabetes; Ischemic outcomes; Obesity; Race

Mesh:

Year:  2017        PMID: 28396226     DOI: 10.1016/j.amjmed.2017.03.030

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).

Authors:  Masaya Koshizaka; Ko Ishikawa; Ryoichi Ishibashi; Yoshiro Maezawa; Kenichi Sakamoto; Daigaku Uchida; Susumu Nakamura; Masaya Yamaga; Hidetaka Yokoh; Akina Kobayashi; Shunichiro Onishi; Kazuki Kobayashi; Jun Ogino; Naotake Hashimoto; Hirotake Tokuyama; Fumio Shimada; Emi Ohara; Takahiro Ishikawa; Mayumi Shoji; Shintaro Ide; Kana Ide; Yusuke Baba; Akiko Hattori; Takumi Kitamoto; Takuro Horikoshi; Ryota Shimofusa; Sho Takahashi; Kengo Nagashima; Yasunori Sato; Minoru Takemoto; Laura Kristin Newby; Koutaro Yokote
Journal:  Diabetes Obes Metab       Date:  2019-05-08       Impact factor: 6.577

2.  Comparison of GRACE and TIMI risk scores in the prediction of in-hospital and long-term outcomes among East Asian non-ST-elevation myocardial infarction patients.

Authors:  Lu Yanqiao; Lan Shen; Miao Yutong; Shen Linghong; He Ben
Journal:  BMC Cardiovasc Disord       Date:  2022-01-07       Impact factor: 2.298

3.  Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case-control analysis.

Authors:  Ebenezer S Owusu Adjah; Srikanth Bellary; Wasim Hanif; Kiran Patel; Kamlesh Khunti; Sanjoy K Paul
Journal:  Cardiovasc Diabetol       Date:  2018-05-15       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.